Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sodium benzoate - SyneuRx

Drug Profile

Sodium benzoate - SyneuRx

Alternative Names: Benzoate - SyneuRx; Clozaben; NaBen; SND 51; SND-11; SND-12; SND-13; SND-14; Tannquilynne

Latest Information Update: 18 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SyneuRx International (Taiwan) corp
  • Class Antidementias; Antifungals; Antipsychotics; Antiseptics; Benzoates
  • Mechanism of Action D amino acid oxidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Schizophrenia
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Schizophrenia
  • Phase II Psychotic disorders
  • No development reported Dementia

Most Recent Events

  • 18 Jun 2024 Chemical structure information added
  • 29 Nov 2023 SyneuRx International terminates due to commercial strategy a phase-II/III clinical trial in Schizophrenia (In adults, Adjuvant therapy) in USA (PO) (NCT02261519)
  • 26 Oct 2023 SyneuRx International (Taiwan) corp terminates a phase IIb/III trials for Schizophrenia (In adolescents, Adjuvant therapy) in USA and Taiwan (PO) (NCT01908192)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top